Xyntha is a Kit in the Plasma Derivative category. It is labeled and distributed by Wyeth Biopharma Division Of Wyeth Pharmaceuticals Llc. The primary component is .
Product ID | 58394-024_0c8fa547-161b-40d8-89a7-5ca96474743d |
NDC | 58394-024 |
Product Type | Plasma Derivative |
Proprietary Name | Xyntha |
Generic Name | Antihemophilic Factor (recombinant) |
Dosage Form | Kit |
Marketing Start Date | 2011-08-01 |
Marketing Category | BLA / BLA |
Application Number | BLA125264 |
Labeler Name | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2011-08-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125264 |
Product Type | PLASMA DERIVATIVE |
Billing Unit | EA |
Marketing Start Date | 2011-08-01 |
NDC | Brand Name | Generic Name |
---|---|---|
58394-014 | Xyntha | Xyntha |
58394-015 | Xyntha | Xyntha |
58394-022 | Xyntha | Xyntha |
58394-024 | Xyntha | Xyntha |
58394-013 | Xyntha | Xyntha |
58394-012 | Xyntha | Xyntha |
58394-016 | Xyntha | Xyntha |
58394-023 | Xyntha | Xyntha |
58394-025 | Xyntha | Xyntha |
0026-3782 | Kogenate FS | Antihemophilic Factor (Recombinant) |
0026-3783 | Kogenate FS | Antihemophilic Factor (Recombinant) |
0026-3785 | Kogenate FS | Antihemophilic Factor (Recombinant) |
0026-3786 | Kogenate FS | Antihemophilic Factor (Recombinant) |
0026-3787 | Kogenate FS | Antihemophilic Factor (Recombinant) |
0026-3821 | Kovaltry | Antihemophilic Factor (Recombinant) |
0026-3822 | Kovaltry | Antihemophilic Factor (Recombinant) |
0026-3824 | Kovaltry | Antihemophilic Factor (Recombinant) |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
XYNTHA 78754885 3535448 Live/Registered |
WYETH LLC 2005-11-16 |
XYNTHA 77380592 3607161 Live/Registered |
WYETH LLC 2008-01-25 |